본문으로 건너뛰기
← 뒤로

Interleukin-11: A pivotal player and potential therapeutic target in prostate cancer.

2/5 보강
Current urology 📖 저널 OA 100% 2024: 2/2 OA 2025: 10/10 OA 2026: 8/8 OA 2024~2026 2026 Vol.20(3) p. 174-179 OA Cytokine Signaling Pathways and Inte
Retraction 확인
출처
PubMed DOI PMC OpenAlex 마지막 보강 2026-04-29
OpenAlex 토픽 · Cytokine Signaling Pathways and Interactions Chemokine receptors and signaling Virus-based gene therapy research

Zhong J, Duan X, Wei Z, Zhu W, Zhao Z, Zeng G

📝 환자 설명용 한 줄

Interleukin-11 (IL-11), a pleiotropic cytokine belonging to the interleukin-6 (IL-6) family, is implicated in the initiation and progression of various malignancies.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Jinghua Zhong, Xiaolu Duan, et al. (2026). Interleukin-11: A pivotal player and potential therapeutic target in prostate cancer.. Current urology, 20(3), 174-179. https://doi.org/10.1097/CU9.0000000000000323
MLA Jinghua Zhong, et al.. "Interleukin-11: A pivotal player and potential therapeutic target in prostate cancer.." Current urology, vol. 20, no. 3, 2026, pp. 174-179.
PMID 41969323 ↗

Abstract

Interleukin-11 (IL-11), a pleiotropic cytokine belonging to the interleukin-6 (IL-6) family, is implicated in the initiation and progression of various malignancies. Recent studies revealed that IL-11 plays multifaceted roles in prostate cancer, contributing to tumor cell proliferation, castration resistance, bone metastasis, and chemotherapeutic resistance. Interleukin-11 has emerged as a promising target for both diagnostic and therapeutic strategies. This review outlines the molecular structure and biological functions of IL-11; summarizes its role in early diagnosis, prognostic evaluation, tumor progression, and therapeutic intervention for prostate cancer; and explores its potential as a novel therapeutic target.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기